Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Finch Therapeutics Group, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 47 | −5 |
| Shares | 10.6M | 942 | 9.86M | −690.3K (−6.5%) |
| Value | $53.1M | $5.00K | $28.0M | −$25.1M (−47.2%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oasis Management Co Ltd. | 225,000 | $639.0K | 0.12% |
| Millennium Management LLC | 91,042 | $259.0K | 0.00% |
| Bridgeway Capital Management, LLC | 52,974 | $150.0K | 0.00% |
| Goldman Sachs Group Inc | 34,511 | $98.0K | 0.00% |
| Wealthsource Partners, LLC | 11,500 | $33.0K | 0.00% |
| Simplex Trading, LLC | 1,679 | $4.00K | 0.00% |
| Credit Suisse AG | 4 | $0 | 0.00% |
| Cutler Group LP | 100 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 63 | $0 | 0.00% |
Sold out (14)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Light Street Capital Management, LLC | 668,757 | $3.36M |
| Qube Research & Technologies Ltd | 37,631 | $189.0K |
| Bank of New York Mellon Corp | 25,037 | $126.0K |
| D. E. Shaw & Co., Inc. | 19,170 | $96.0K |
| Nuveen Asset Management, LLC | 12,002 | $64.0K |
| Deutsche Bank AG | 4,105 | $21.0K |
| American International Group, Inc. | 3,758 | $19.0K |
| JPMorgan Chase & Co | 3,550 | $18.0K |
| California State Teachers Retirement System | 3,184 | $16.0K |
| STRS Ohio | 1,800 | $9.00K |
| Amalgamated Bank | 942 | $5.00K |
| Legal & General Group Plc | 603 | $3.00K |
| Ameritas Investment Partners, Inc. | 593 | $3.00K |
| Royal Bank of Canada | 465 | $2.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 942 | $5.00K |